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doi:10.1016/j.kjms.2011.06.034Abstract Basaloid follicular hamartoma (BFH) is a rare, benign, skin adnexal tumor. Several
clinical patterns have been reported, but they all share the same histopathological features.
BFH may be hereditary or nonhereditary and can be accompanied by systemic diseases. Micro-
scopic examination of BFH shows branching cords and anastomosing strands of basaloid cells in
a loose, fibrous stroma. The most important pathological differential diagnosis is infundibulo-
cystic basal cell carcinoma. These two lesions must be differentiated carefully based on
clinical presentation and histopathological picture, and even molecular studies may be
needed. We present a report of a 78-year-old woman with a solitary, asymptomatic, slow-
growing skin tumor on her left scalp. No associated systemic disorders were found. On the basis
of an excisional biopsy performed on the tumor, a pathological diagnosis of sporadic BFH was
made.
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.Introduction
Basaloid follicular hamartoma (BFH) is a malformation of
a hair follicle and is restricted to the superficial dermis
[1,2]. BFH can be associated with several systemic diseases,
such as myasthenia gravis, systemic lupus erythematosus,
and alopecia. There is a likelihood that the incidence of
BFH may be underestimated because of its benign courseof Pathology and Laboratory
rial Hospital, No. 95, Wen-
y 11101, Taiwan.
com.tw (C.-C. Lee).
vier Taiwan LLC. All rights reservand also because the occurrence of BFH is very rare. In this
article, we present a case of a solitary BFH on the left scalp
in a patient and review the clinical presentation and
histopathological differential diagnosis.Case presentation
A 78-year-old woman had a skin tumor on her left scalp
for more than 2 years. The tumor was stable and asymp-
tomatic without itching or tenderness. She presented to
the Department of General Surgery at Shin-Kong Wu
Ho-Su Memorial Hospital for management in December
2009. Physical examination showed a smooth surfaced,ed.
Figure 2. The cords and strands are composed of a few
layers of basaloid cells. The tumor cells are relatively uniform
with bland-looking nuclei. The stroma is hypocellular and
myxoid. There is no cleft between epithelial strands and
stroma (hematoxylin and eosin: 400).
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temporofrontal area of the left scalp. It was well defined
and elastic on palpation. There was no other similar skin
lesion. The patient did not have alopecia, ptosis,
dysphagia, or diplopia. She had no family history on record
for similar lesions. An excisional biopsy of the tumor was
done, and the specimen was sent for histopathological
examination.
Microscopically, the tumor was characterized by
branching cords and anastomosing strands of basaloid cells
embedded in a loose, fibrous stroma. The tumor was well
demarcated and located in the superficial dermis (Fig. 1).
The cords and strands were formed by two to four layers of
basaloid cells (Fig. 2). Peripheral palisading was not seen.
Horn cysts and abortive hair follicleelike structures were
present in the tumor (Fig. 3). No mucinous areas were
identified. There were no cleft-like spaces between the
stroma and the epithelial strands. The epidermis was
atrophic but intact. The tumor was not associated with the
hair follicles nor was it connected with the epidermis. The
tumor cells were uniform with bland-looking nuclei and
eosinophilic cytoplasm. No squamoid cell was identified.
Mitoses were absent. Immunohistochemical stains for Ki-67
(Cellular marker for proliferation), Bcl-2 (B-cell lymphoma
2), CD34, and CD10 were performed (Fig. 4). Very few
tumor cells showed nuclear positivity for Ki-67, and only the
peripheral tumor cells showed weak cytoplasmic positivity
for Bcl-2. The stromal cells showed positive staining against
CD34. CD10 stained weakly for the stromal cells but not the
tumor cells. Based on the histopathological features,
immunohistochemical studies, and stable clinical presen-
tation, a diagnosis of a solitary BFH was made.
Discussion
BFH is a unique, benign, skin adnexal tumor. In 1969, this
tumor was first reported under the title “generalized hair
follicle hamartoma” with associated alopecia, aminoacid-
uria, and myasthenia gravis [3]. Mehregan and Baker [1]
first used the term “basaloid follicular hamartoma” toFigure 1. The scalp tumor comprising branching cords and
anastomosing strands sitting in the superficial dermis. The
border is clear (hematoxylin and eosin: 40).
Figure 3. (A) A horn cyst with keratin can be seen in the
tumor. The overlying epidermis is intact (hematoxylin and
eosin: 100). (B) Keratinizing material surrounded by
tumor cells that form an abortive hair follicleelike structure
(hematoxylin and eosin: 400).
Figure 4. Immunohistochemical stains. (A) Very few tumor cells show nuclear positivity for Ki-67 (400); (B) Low-power view of
Bcl-2 shows that only the peripheral tumor cells are weakly positive (Bcl-2: 100); (C) The stroma cells showing positive staining for
CD34 (400); (D) The stromal cells showing weak positive staining for CD10 and the tumor cells that are negative (CD10: 400).
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cases have been reported. Morohashi et al. [2], based on
ultrastructural and immunohistochemical studies, thought
that BFH was an abortive growth of secondary hair germs
with a limited differentiation toward the upper follicular
portion of the hair shaft.
The pathogenesis of BFH is found to be associated with
the patched (PTCH: Protein patched homolg) gene muta-
tion on chromosome 9q23. The PTCH gene encodes
a receptor involved in the sonic hedgehog-patched-Gli
(Products of Glioma-associated oncogene) signal pathway
[4]. Mutations in this signal pathway can lead to abnormal
growth and patterning of cells.
BFH may manifest in multiple clinical presentations,
such as multiple lesions with a generalized or localized
distribution, or as a solitary lesion. Several forms of
generalized BFH have been described: (1) sporadic form:
multiple BFHs without systemic disease [5]; (2) acquired
form: female patients with generalized BFHs associated
with alopecia and autoimmune diseases, such as myas-
thenia gravis or systemic lupus erythematosus [6,7]; (3)
familial form: an autosomal dominant disease that may or
may not be associated with hypotrichosis, hypohidrosis, and
palmoplantar pitting [8e10]; and (4) congenital form:
generalized BFHs associated with alopecia and cystic
fibrosis [11].
The localized forms of BFH present as linear unilateral
lesions or as plaques with alopecia [1,2,12,13]. The linear
unilateral type of BFH is associated with lines of Blaschko
and presents at birth or appears in early childhood
[1,12,13].Solitary BFH was first described in 1992 as a smooth
plaque or a papule appearing most commonly on the face or
scalp as in our case [5]. The incidence of solitary BFH may
be underestimated because solitary BFH is usually asymp-
tomatic and stable.
Although there are many clinical forms of BFH, they all
share the same unique histopathological features as previ-
ously described in our case. BFH is a folliculocentric tumor
limited to superficial dermis. Deep reticular dermis or soft
tissue involvement is not typical of this disease. In early
lesions, the branching cords of basaloid cells connecting
the central pilosebaceous structures can be seen. In long-
standing cases, the central pilosebaceous structures may
be totally replaced by the tumor [14].
Histopathological differential diagnosis includes (1) tri-
choepithelioma, (2) fibrofolliculoma, (3) fibroepithelioma
of Pinkus, (4) folliculocentric basaloid proliferation, and (5)
infundibulocystic basal cell carcinoma (IFBCC).
Trichoepitheliomas are usually larger than BFH. The
tumor islands of basaloid cells may have “swiss cheese” or
lace-like pattern with no branching tumor strands. The
stroma of trichoepithelioma is more cellular than that of
BFH [5,15].
Fibrofolliculoma is another type of tumor with epithelial
strands embedded in a fibrous stroma. Compared with BFH,
fibrofolliculoma has much more prominent stroma and less
amount of epithelial strands [5]. In some areas, no
epithelial strands can be found [15].
Fibroepithelioma of Pinkus is a variant of basal cell
carcinoma (BCC), which is characterized by arborizing cords
of basaloid cells from epidermis and may be identical to
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seen in BFH, may be present in some epithelial cords of
fibroepithelioma of Pinkus. In addition, fibroepithelioma of
Pinkus is surrounded by more prominent fibrovascular
stroma [10,15].
Folliculocentric basaloid proliferation occurs in the skin
adjacent to a BCC [16]. It is a reactive lesion characterized
by folliculocentric, vertically oriented basaloid aggregates
with histologically unaltered stroma [16]. Most of the
basaloid aggregates are surrounded by a prominent hyaline
basement membrane. The folliculocentric basaloid prolif-
eration has no keratin cysts, which is the most notable
difference from BFH [16].
The most important histopathological differential diag-
nosis of BFH is the IFBCC. IFBCC is formed by cords and
strands of basaloid cells embedded in a loose, fibrous
stroma, as in BFH [15]. Horn cysts can also be found in
IFBCC. IFBCC is not a folliculocentric tumor like BFH and
may be located in the interfollicular dermis [10]. Pilose-
baceous structures are usually destroyed by the tumor cells
and, thus, are not seen in IFBCC. Deep infiltration,
epidermal ulceration, and clinical rapid growth also imply
a diagnosis of IFBCC [10,15]. Immunohistochemical stains
using proliferative antibodies, such as Ki-67, and prolifer-
ating cell nuclear antigen have a more intense reaction in
IFBCC than in BFH [14]. Bcl-2 stains only the outermost
tumor cells of BFH but is more prominent in BCC [17]. The
stromal cells of the BFH stain positive for CD34, but the
stromal cells of BCC are negative. CD10 stains both the
stromal and tumor cells of BCC, whereas it stains only
weakly in the stromal cells of BFH [17]. At the molecular
level, both IFBCC and BFH have abnormal PTCH signaling
pathways. However, the degree of aberrant overexpression
of PTCH mRNA is higher in IFBCC [14].
The clinical significance of BFH is that it can be mistaken
for BCC clinically and histologically, especially the IFBCC
subtype. They must be differentiated carefully because BFH
is a benign tumor, and BCC is malignant. Excisional biopsy
with adequate resectionmargin is needed for BCC because it
is a locally invasive tumor and rarely can metastasize.
Moreover, about half of the patients who are diagnosed with
BCC may develop new lesions within 5 years [18]. Avoiding
sun exposure and regular skin screening are recommended
for patients with BCC. On the other hand, BFH is clinically
stable and limited in the superficial dermis. Surgical treat-
ment is not usually needed except for cosmetic reasons or to
exclude other skin tumors. We present a report of this rare
skin tumor to emphasize its unique histopathological picture
and benign nature. When multiple BFH lesions are present,
clinicians should be aware that they may be associated with
systemic diseases. BCC can rarely develop in BFH [19].
Biopsy should be done on rapidly growing lesions or lesions
that exhibit a change in clinical appearance [10].
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